Scientists track 637 patients to crack code of stubborn cancer type
NCT ID NCT05511688
Summary
This study is observing 637 patients with a specific genetic type of colorectal cancer called MSI. The goal is to collect detailed information to better understand how this cancer behaves, which treatments work best, and what factors predict patient outcomes. It is an observational study, meaning it gathers data but does not test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH
Abbeville, France
-
CH
Angoulême, France
-
Ch - Centre Hospitalier de Bézier
Béziers, France
-
Ch - Ght Unyon Auxerre
Auxerre, France
-
Ch - Hôpital Henri Duffaut
Avignon, France
-
Ch - Hôpital Victor Dupouy
Argenteuil, France
-
Chu - Hôpital Hôtel Dieu
Angers, France
-
Chu - Hôpital Jean Minjoz
Besançon, France
-
Chu - Hôpital Sud
Amiens, France
-
Chu Poitiers
Poitiers, VIENNE, 86021, France
-
Privé - Clinique Tivoli
Bordeaux, France
-
Privé - Institut Du Cancer Avignon Provence
Avignon, France
-
Privé - Polyclinique Bordeaux Nord
Bordeaux, France
-
Privé- Centre Pierre Curie
Beuvry, France
Conditions
Explore the condition pages connected to this study.